Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_assertion type Assertion NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_head.
- NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_assertion description "[FOXD1 and FOXD2 were more highly expressed in prostate cancer and lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_provenance.
- NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_assertion evidence source_evidence_literature NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_provenance.
- NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_assertion SIO_000772 19220249 NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_provenance.
- NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_assertion wasDerivedFrom befree-20140225 NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_provenance.
- NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_assertion wasGeneratedBy ECO_0000203 NP569699.RAwZUxWUhdOe7I0YmwdlH-SFR8OdcvdQ5Ol9byg2QwNjg130_provenance.